Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months’ follow-up

Longitudinal Study
DOI: 10.1016/j.ijid.2022.06.031 Publication Date: 2022-06-23T16:04:37Z
ABSTRACT
Persistence of COVID-19 symptoms in nonhospitalized individuals beyond a few months has not been well characterized. In this longitudinal study from the Faroe Islands, we present prevalence long COVID mainly patients who were followed up for to 8 months.All Faroese with confirmed diagnosis August December 2020 invited participate (n = 297). Demographic and clinical characteristics self-reported ascertained prospectively using detailed questionnaire administered at repeated phone interviews.A total 226 participated baseline (226/297, 76% participation rate), whom 170 participants had more than 3 follow-up. Of these, 39% 67/170, 95% confidence interval [CI] 32-37%) reported persistent (median [range] 168 [93-231] days) after acute phase 8% 14/170, CI 5-13%) severe symptoms. The most prevalent fatigue (17%) smell taste (14%) dysfunction. Long was common people reporting daily medication use (odds ratio 2.34, 1.02-5.37).Our results show that may take resolve, even among individuals, mild illness phase. Continued monitoring is needed evaluate added risk potential public health concern.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (23)